Trial Profile
Cohort Study of the Clinical Course of Macular Diseases in Kagawa (Kagawa Macula Cohort Study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Pegaptanib (Primary) ; Ranibizumab (Primary) ; Verteporfin (Primary)
- Indications Age-related macular degeneration; Central serous chorioretinopathy; Choroidal neovascularisation; Diabetic macular oedema; Retinal perforations; Retinal vein occlusion
- Focus Therapeutic Use
- 27 Dec 2014 New trial record